Related Experiment Video
Updated: Jun 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Potentiating the p53 network
Daniel Menendez1, Alberto Inga, Michael A Resnick
1Chromosome Stability Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, USA. resnick@niehs.nih.gov
Abstract:
Expression of the p53 tumor suppressor, which has many roles in human biology, is altered in almost all cancers. It is a highly regulated sequence-specific transcription factor that is activated by a variety of cellular stresses including DNA damage. Central to its transactivation function as a master transcriptional regulator of hundreds of genes are the DNA target sequences bound by p53, where the canonical consensus target has generally been considered to be composed of two decameric half-sites (RRRCWWGYYY) separated by a variable spacer. Knowledge of p53 binding and transactivation at various p53 target sequences is important to understanding the biological role of this well-known "guardian of the genome." Recently we reported that both wild-type and mutant p53 can also drive transactivation at noncanonical half-site response elements (REs), a finding that greatly expands the universe of genes and regions potentially affected by p53. Furthermore, we found that p53-mediated transcription can be dramatically increased in conjunction with estrogen receptor (ER) transcription factors acting in cis at a nearby ER target sequence. Here we address the functionality of canonical and noncanonical REs in supporting transactivation by both wild-type and cancer-associated mutant p53s as well as transcriptional synergism of p53 with ER. Our findings have important implications for cellular and tissue responses to various stresses.
Insights
The p53 tumor suppressor protein regulates genes by binding to DNA. This study reveals p53 also binds noncanonical sites and works with estrogen receptors, expanding its role in cancer and stress responses.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The p53 tumor suppressor is a critical regulator of cellular responses to stress, with its expression altered in most cancers.
- p53 functions as a sequence-specific transcription factor, binding to DNA target sequences to regulate gene expression.
- The canonical p53 DNA response element consists of two decameric half-sites separated by a variable spacer.
Purpose of the Study:
- To investigate the functionality of canonical and noncanonical p53 response elements (REs) in supporting transactivation by wild-type and mutant p53.
- To examine the transcriptional synergism between p53 and the estrogen receptor (ER).
- To expand the understanding of genes and genomic regions potentially influenced by p53.
Main Methods:
- Analysis of p53 binding and transactivation at canonical and noncanonical REs.
- Assessment of wild-type and cancer-associated mutant p53 activity.
- Investigation of p53 and ER synergistic transcriptional activity.
Main Results:
- Both wild-type and mutant p53 can drive transactivation at noncanonical half-site REs, expanding the scope of p53 regulation.
- p53-mediated transcription is significantly enhanced by estrogen receptor (ER) acting in cis at a nearby ER target sequence.
- The functionality of both canonical and noncanonical REs in supporting p53 transactivation and ER synergism was characterized.
Conclusions:
- p53's regulatory role extends beyond canonical DNA binding sites to include noncanonical elements.
- The interplay between p53 and ER offers new insights into transcriptional regulation in cancer and response to cellular stress.
- These findings have significant implications for understanding cellular and tissue responses to various stresses.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway